1-3 of 3
Timo Behlendorf
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment of Immune Thrombocytopenia (ITP) with Eltrombopag - Results of the 5 th Interim Analysis of the Study RISA, with Special Consideration of Treatment Discontinuations

Oliver Meyer, Rudolf Schlag, Thomas Stauch, Bastian Fleischmann, Marcel Reiser, Dietrich Kaempfe, Timo Behlendorf, Manfred Welslau, Eyck von der Heyde, Steffen Dörfel, Claudia Willy, Martina Stauch
Journal: Blood
Blood (2022) 140 (Supplement 1): 2683–2684.
https://doi.org/10.1182/blood-2022-166741
Published: 2022
Journal Articles

Treatment of Immune Thrombocytopenia (ITP) with Eltrombopag - Results of the 4 th Interim Analysis of the German Non-Interventional Trial RISA

Oliver Meyer, Rudolf Schlag, Thomas Stauch, Bastian Fleischmann, Marcel Reiser, Dietrich Kaempfe, Timo Behlendorf, Manfred Welslau, Claudia Willy, Martina Stauch
Journal: Blood
Blood (2021) 138 (Supplement 1): 3150.
https://doi.org/10.1182/blood-2021-146809
Published: 2021
Journal Articles

Crizotinib in ALK-Positive Diffuse Large B-Cell Lymphoma: A Case Report

Maxi Wass, MD, Timo Behlendorf, MD, Ulrike Gläser, MD, Jörn Rüssel, MD, Fredericke Güntsch, MD, Jordan Karin, MD, Hans-Joachim Schmoll, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4862.
https://doi.org/10.1182/blood.V120.21.4862.4862
Published: 2012